← FDA Drug Approvals (Drugs@FDA)
DIDANOSINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO · Approved 2012-08-14
Drug application
- FDA Application #
ANDA077275
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIDANOSINE
- Generic name
- Didanosine
- Active ingredients
- DIDANOSINE
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO
- First approval
- 2012-08-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown